Metraipolis › archive › dc_0cda96aceafb

Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosis — Europe PMC PMID:41859417

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41859417
DOI
10.3389/fneur.2026.1747131
License (as archived)
solo-consultazione
Archived
2026-11-05T03:44:53.486Z
SHA-256 of the archived text
24b427d3432c7008b5c521ffd8fdf0ff20518949750c02fcf96ebb6ee37139a7
Stable URL of this page
https://metraipolis.com/documento/dc_0cda96aceafb

How to cite

Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosis — Europe PMC PMID:41859417 — Europe PMC (en), https://europepmc.org/article/MED/41859417 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0cda96aceafb (Metraipolis archive dc_0cda96aceafb, sha256 24b427d3432c7008b5c521ffd8fdf0ff20518949750c02fcf96ebb6ee37139a7)
BibTeX
@misc{dc0cda96aceafb,
  title = {Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosis — Europe PMC PMID:41859417},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41859417},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0cda96aceafb; sha256 24b427d3432c7008b5c521ffd8fdf0ff20518949750c02fcf96ebb6ee37139a7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41859417. Agents can read the archived copy with the MCP tool read_document.